EVH Share Price Performance
US$2.83
-7.31 (-72.09%)
45.4% undervalued intrinsic discount
US$5.18
Fair Value
Price US$2.83
AnalystConsensusTarget US$5.18
AnalystHighTarget US$14.31
AnalystLowTarget US$6.00
Fair ValueUS$5.18
Share Pricen/a
Evolent Health, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
EVH Community Narratives
AN
Fair Value US$5.18 45.4% undervalued intrinsic discount
Value-based Care And Digital Automation Will Expand Future Opportunities
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
Fair Value US$14.31 80.2% undervalued intrinsic discount
Aetna Partnership And Demographic Trends Will Redefine Care Delivery
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$6 52.8% undervalued intrinsic discount
Digital Health Rivals And Regulatory Hurdles Will Erode Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Value-based Care And Digital Automation Will Expand Future Opportunities
Key Takeaways Accelerating demand for value-based care and advanced tech platforms is boosting Evolent's market expansion, long-term revenue growth, and client retention. Investments in AI, proprietary programs, and regulatory tailwinds are improving margins, reducing costs, and enabling profitable market share gains over legacy solutions.Read more
72
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
US$5.18
45.4% undervalued intrinsic discount
Fair Value
Profit Margin
6.33%
Future PE
3.52x
Price in 2029
US$7.28
Aetna Partnership And Demographic Trends Will Redefine Care Delivery
Key Takeaways AI-driven automation and improved contract structures are expected to significantly boost margins, stabilize earnings, and enhance operational efficiencies well beyond industry norms. Strategic partnerships and expanding value-based care solutions position Evolent for accelerated, multi-year revenue growth, increased client diversification, and industry-leading market share gains.Read more
29
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$14.31
80.2% undervalued intrinsic discount
Fair Value
Profit Margin
0.19%
Future PE
328.5x
Price in 2029
US$20.21
Digital Health Rivals And Regulatory Hurdles Will Erode Prospects
Key Takeaways Intensifying competition and client internalization threaten Evolent's market position, shrinking its addressable market and challenging its ability to grow revenue and margins. Heightened regulatory scrutiny and heavy client concentration pose risks to pricing, earnings stability, and long-term financial performance.Read more
10
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$6
52.8% undervalued intrinsic discount
Fair Value
Profit Margin
6.93%
Future PE
4.2x
Price in 2029
US$8.47
Trending Discussion
Recently Updated Narratives
AN
EVH: ACA Membership Stability And Conservative Reserves Will Support Margin Recovery
Fair Value: US$5.18 45.4% undervalued intrinsic discount
9 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EVH: Future Contracts And Pipeline Are Expected To Support Margins Beyond 2025
Fair Value: US$14.31 80.2% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EVH: Contract Pipeline And AI Initiatives Will Underpin Post 2026 EBITDA Upside
Fair Value: US$6 52.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Evolent Health, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -5.19
- 21.31%
- -30.88%
- 233.8%
About EVH
- Founded
- 2011
- Employees
- 4200
- CEO
- WebsiteView website
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
